Adamax

ADAMAX is a synthetic hexapeptide incorporating an adamantane moiety, developed for experimental investigation of peptide stability, membrane interaction, and peptide–receptor or peptide–protein interaction dynamics in in vitro research systems. The adamantyl modification is used as a structural tool to enhance lipophilicity and alter physicochemical behaviour relative to non-modified peptide analogues.

RESEARCH APPLICATIONS INCLUDE:

• BDNF upregulation and neurotrophic factor pathway modulation studies
• Cognitive function, memory consolidation and learning research models
• Neuroprotective mechanism investigation against hypoxia and oxidative stress
• Neurotransmitter system modulation (dopaminergic, serotonergic, cholinergic)
• Enkephalin degradation inhibition and endogenous opioid pathway research
• Comparative nootropic peptide research vs Selank and other CNS compounds

PRODUCT SPECIFICATIONS:

• Form: Lyophilised powder
• Purity: ≥99% 
• Storage: −20°C, protected from light and moisture
• Available strength: 10mg 

⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use